Epitomee Medical (XTAE:EPIT) Cash-to-Debt : 8.79 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Epitomee Medical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Epitomee Medical's cash to debt ratio for the quarter that ended in Dec. 2023 was 8.79.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Epitomee Medical could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Epitomee Medical's Cash-to-Debt or its related term are showing as below:

XTAE:EPIT' s Cash-to-Debt Range Over the Past 10 Years
Min: 3.02 Med: 10.04 Max: 110.9
Current: 8.79

During the past 6 years, Epitomee Medical's highest Cash to Debt Ratio was 110.90. The lowest was 3.02. And the median was 10.04.

XTAE:EPIT's Cash-to-Debt is ranked better than
71.63% of 839 companies
in the Medical Devices & Instruments industry
Industry Median: 1.98 vs XTAE:EPIT: 8.79

Epitomee Medical Cash-to-Debt Historical Data

The historical data trend for Epitomee Medical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Epitomee Medical Cash-to-Debt Chart

Epitomee Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

16.16

3.02

110.88

11.30

8.79

Epitomee Medical Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial				110.88	120.87	11.30	10.29	8.79

Competitive Comparison of Epitomee Medical's Cash-to-Debt

For the Medical Devices subindustry, Epitomee Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epitomee Medical's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's Cash-to-Debt falls into.

Epitomee Medical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Epitomee Medical's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	127.274	/	(1.643	+	12.838)
	=	8.79

Epitomee Medical's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	127.274	/	(1.643	+	12.838)
	=	8.79

Epitomee Medical (XTAE:EPIT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Epitomee Medical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Epitomee Medical (XTAE:EPIT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (XTAE:EPIT) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

EPTMF:USA

Address

Tarshish 19, Caesarea, ISR, 3088900

Website

https://www.epitomeemedical.com

Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.

Epitomee Medical (XTAE:EPIT) Headlines

No Headlines